Medical Equipment

Gastric Cancer Diagnostic Market 2026–2030: Forecasting Business Opportunities Ahead

February 5, 2026February 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How is the Gastric Cancer Diagnostic Market size predicted to change over the forecast window of 2026–2035?

The gastric cancer diagnostic market has shown significant expansion in recent years. It is projected to increase from $2.78 billion in 2025 to $2.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to several factors, including the limited availability of fluorescent probes, a reliance on traditional single-color FISH methods, burgeoning genetic research initiatives, expanding hospital and laboratory infrastructure, and the uptake of basic cytogenetic diagnostics.

The gastric cancer diagnostic market is anticipated to experience robust growth over the next few years, with projections indicating it will expand to $3.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This expansion during the forecast period is fueled by the development of multiplex and high-throughput probes, an increasing demand for precision medicine, the broadening scope of genetic and pharmaceutical research, technological progress in imaging and quantification, and heightened regulatory compliance and quality standards. Prominent trends for the forecast period include the surging adoption of multiplex and high-throughput FISH probes, the wider application of genetic and molecular diagnostics, their growing utilization in clinical and pharmaceutical research, integration with advanced imaging and analysis technologies, and a stronger focus on the accuracy and sensitivity of probes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27291&type=smp

Which Drivers Are Contributing To The Expansion Of The Gastric Cancer Diagnostic Market?

The increasing occurrence of gastric cancer is anticipated to drive expansion within the gastric cancer diagnostic market in the future. Gastric cancer is defined as a malignant tumor forming in the stomach lining, characterized by uncontrolled cell growth that creates a mass capable of invading adjacent tissues and metastasizing throughout the body. This surge in gastric cancer cases is linked to poor dietary choices, specifically the frequent intake of salted, smoked, and processed foods, which elevate the risk of stomach lining damage and subsequent cancer development. Gastric cancer diagnostic tools assist in diagnosing gastric cancer by allowing for the early discovery of malignant lesions, thereby facilitating prompt treatment and enhancing patient prognoses. These diagnostics boost clinical effectiveness through accurate and swift results, aiding in superior disease management. As an illustration, in May 2024, data from the American Cancer Society, a US-based nonprofit, indicated that new stomach cancer cases climbed to 26,890 in 2024, up from 26,500 cases reported in 2023. Consequently, the growing prevalence of gastric cancer is fueling the expansion of the gastric cancer diagnostic market.

What Segment Categories Are Covered In The Gastric Cancer Diagnostic Market?

The gastric cancer diagnostic market covered in this report is segmented –

1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing

2) By Product: Reagents And Consumables, Instruments

3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies

4) By Application: Early Diagnosis, Screening, Monitoring

5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy

2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound

3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy

4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology

5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing

Which Innovation Trends Are Advancing Developments Within The Gastric Cancer Diagnostic Market?

Leading companies in the gastric cancer diagnostic market are concentrating on developing innovative diagnostic tools, such as artificial intelligence-based endoscopic diagnostic support devices, to enhance early detection and accuracy. These AI-powered tools are designed to assist in identifying and evaluating gastrointestinal abnormalities during endoscopy. For example, in March 2024, AI Medical Service Inc., a Japan-based medical technology firm, introduced GastroAI-model G, an AI-driven endoscopic diagnostic support system. This system aids gastroenterologists during endoscopic procedures by analyzing video images in real time to pinpoint potential cancerous lesions. It employs deep learning to detect suspicious areas indicative of early gastric cancer, which may warrant a biopsy or further examination. When such lesions are identified, the system promptly alerts the physician by highlighting the area with a rectangle on the endoscopic screen, thereby improving diagnostic accuracy and enabling early cancer detection.

Which Major Firms Are Strengthening Their Position In The Gastric Cancer Diagnostic Market?

Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Gastric Cancer Diagnostic Market?

North America was the largest region in the gastric cancer diagnostic market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastric Cancer Diagnostic Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27291&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Market 2026, By The Business Research Company

Thermal Insulation Material Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thermal-insulation-material-global-market-report

Building Insulation Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Insulation Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795